Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Role of the USP7/FOXO3A axis in environmentally relevant doses of arsenic-induced lung carcinogenesis: Insights from bioinformatics analysis and model of human epithelial cell malignant transformation. | Ecotoxicol Environ Saf | 2025 | 40273609 | PubTator, text mining | PubMed |
| Rational Computational Workflow for Structure-Guided Discovery of a Novel USP7 Inhibitor. | J Chem Inf Model | 2025 | 40263111 | PubTator, text mining | PubMed |
| Structural insights into the interaction between testis-specific Y-encoded-like protein 5 and ubiquitin-specific protease 7. | Protein Sci | 2025 | 40260937 | PubTator, text mining | PubMed |
A new perspective: Acyl-CoA synthetase long-chain family member 4 inhibits ubiquitin-specific protease 7-induced epithelial ovarian cancer progression by inducing ferroptosis and M1 macrophage polarization. | Cytojournal | 2025 | 40260070 | PubTator, text mining | PubMed |
| Data Exploration for Target Predictions Using Proprietary and Publicly Available Data Sets. | Chem Res Toxicol | 2025 | 40253625 | PubTator, text mining | PubMed |
| Harnessing the Deubiquitinase USP1 for Targeted Protein Stabilization. | J Am Chem Soc | 2025 | 40252079 | PubTator, text mining | PubMed |
| USP7 promotes the malignant progression of osteosarcoma through the KPNA2/PKLR axis. | Cell Signal | 2025 | 40250695 | PubTator, text mining | PubMed |
| USP7 promotes endothelial activation to aggravate sepsis-induced acute lung injury through PDK1/AKT/NF-κB signaling pathway. | Cell Death Discov | 2025 | 40246841 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies. | J Med Chem | 2025 | 40237780 | PubTator, text mining | PubMed |
| USP28-Based Deubiquitinase-Targeting Chimeras for Cancer Treatment. | J Am Chem Soc | 2025 | 40214647 | PubTator, text mining | PubMed |
| Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant Melanoma. | J Invest Dermatol | 2025 | 40204067 | PubTator, text mining | PubMed |
| Computational analysis of energetic features and intermolecular interactions in protein-inhibitor USP7 complexes. | Org Biomol Chem | 2025 | 40192453 | PubTator, text mining | PubMed |
| Targeting USP47 enhances the efficacy of KRAS inhibitor in KRASG12C mutated non-small cell lung cancer by controlling deubiquitination of c-Myc. | Pharmacol Res | 2025 | 40180254 | PubTator, text mining | PubMed |
| Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP. | Drug Des Devel Ther | 2025 | 40165995 | PubTator, text mining | PubMed |
| Three new Pseudogymnoascus species (Pseudeurotiaceae, Thelebolales) described from Antarctic soils. | IMA Fungus | 2025 | 40162003 | PubTator, text mining | PubMed |
| CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1. | Cell Mol Biol Lett | 2025 | 40158127 | PubTator, text mining | PubMed |
| Activation of TRAF1 induced by USP7/SP1 exacerbates the severity of infantile pneumonia. | Hereditas | 2025 | 40121492 | PubTator, text mining | PubMed |
| TAOK1 promotes filament formation in HR repair through phosphorylating USP7. | Proc Natl Acad Sci U S A | 2025 | 40106350 | PubTator, text mining | PubMed |
| Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality. | iScience | 2025 | 40104064 | PubTator, text mining | PubMed |
| USP7 V517F mutation as a mechanism of inhibitor resistance. | Nat Commun | 2025 | 40087304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=13